Víctor
Blanco Gozalo
Investigador no período 2016-2017
Instituto de Estudios de Ciencias de la Salud de Castilla y León
Soria, EspañaPublicacións en colaboración con investigadores/as de Instituto de Estudios de Ciencias de la Salud de Castilla y León (8)
2021
-
Urinary Plasminogen Activator Inhibitor-1: A Biomarker of Acute Tubular Injury
American Journal of Nephrology, Vol. 52, Núm. 9, pp. 714-724
2020
-
Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury
Scientific Reports, Vol. 10, Núm. 1
-
Impaired Tubular Reabsorption Is the Main Mechanism Explaining Increases in Urinary NGAL Excretion Following Acute Kidney Injury in Rats
Toxicological sciences : an official journal of the Society of Toxicology, Vol. 175, Núm. 1, pp. 75-86
-
Pathophysiological mechanisms underlying a rat model of triple whammy acute kidney injury
Laboratory Investigation, Vol. 100, Núm. 11, pp. 1455-1464
-
Urinary TCP1-eta: A Cortical Damage Marker for the Pathophysiological Diagnosis and Prognosis of Acute Kidney Injury
Toxicological Sciences, Vol. 174, Núm. 1, pp. 3-15
2016
-
Cardiotrophin-1 therapy prevents gentamicin-induced nephrotoxicity in rats
Pharmacological Research, Vol. 107, pp. 137-146
2015
-
Sub-nephrotoxic cisplatin sensitizes rats to acute renal failure and increases urinary excretion of fumarylacetoacetase
Toxicology Letters, Vol. 234, Núm. 2, pp. 99-109
-
Urinary proteomics in renal pathophysiology: Impact of proteinuria
Proteomics - Clinical Applications, Vol. 9, Núm. 5-6, pp. 636-640